Recent legal developments highlight increased risk and scrutiny in two important areas for employer‑sponsored health plans: international prescription drug sourcing and mental health parity (MHPAEA) compliance.
International Prescription Drug Sourcing
A recent lawsuit involving an employer health plan and an alternative Rx funding program raises serious concerns about safety and compliance related to importing prescription drugs from outside the U.S.
The lawsuit alleges risks including:
- Use of foreign, unapproved drugs
- Differences between U.S.‑approved medications and imported versions
- Confusion for patients, particularly those with serious conditions
- Limited regulatory oversight and enforcement
International Rx sourcing has grown quickly and often operates in a legal gray area. These developments suggest the issue goes beyond cost management and can involve patient health and safety risks. Employers considering alternative funding vendors or international sourcing programs should consult legal counsel before proceeding.
Mental Health Parity Settlements (MHPAEA)
Two recent settlements reinforce that regulators are increasing enforcement around mental health and substance use disorder (MH/SUD) access.
Key themes from these settlements:
- Plans must provide timely access to in‑network MH/SUD care
- Inaccurate provider directories (“ghost networks”) are a compliance risk
- When in‑network access is insufficient, plans should allow out‑of‑network care at in‑network cost sharing
- Ongoing monitoring and documentation of network adequacy are critical
These cases show that regulators expect plans to actively address access issues—even during disruptions like staffing shortages or strikes.
Employer Takeaways
- Employers are fiduciaries and share responsibility for benefit plan compliance, even when insurers or TPAs are involved
- Employers with 50+ employees should obtain and maintain their MHPAEA Non‑Quantitative Treatment Limitation (NQTL) comparative analysis
- Employers should document:
- Oversight of MH/SUD networks
- Communications with carriers or TPAs
- Steps taken to address access challenges
Bottom Line
These lawsuits and settlements signal closer scrutiny of both Rx cost strategies and mental health access. Employers should approach alternative Rx solutions cautiously, stay attentive to mental health network adequacy, and ensure fiduciary oversight is properly documented.
We are continuing to monitor these developments and will share updates as guidance evolves.
COMMENTS